13D Filing: James E. Flynn and Nivalis Therapeutics Inc. (NVLS)
...
Novellus Systems Inc (NVLS)
Get Email AlertsSector: Special Industry Machinery, Nec
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | 0 | $0 | 0% |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.37 | 2,500 | Officer | 0 | 2012-04-16 | Filing | |
| $47.37 | 197 | Officer | 0 | 2012-04-16 | Filing | |
| $47.37 | 791 | Officer | 197 | 2012-04-16 | Filing | |
| $47.36 | 50,000 | Officer | 10,508 | 2012-04-12 | Filing | |
| $47.55 | 37,500 | Officer | 10,508 | 2012-04-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 176,000 | $3,333 | 0.01% | |
| 2. | 98,000 | $1,856 | 0.15% | |
| 3. | 17,000 | $322 | 0.01% | |
| 4. | 1 | $0 | 0% |
News See All
Here’s What Happened With Cyclacel Pharmaceuticals Inc (CYCC) And Nivalis Therapeutics Inc (NVLS)
This week was a good one for a few biotechs, but not so great for others. Two in particular have just put out news relating to trials for their lead investigative assets, and both have taken a hit on...
Here’s What Happens Now At Nivalis Therapeutics Inc (NVLS)
Nivalis Therapeutics Inc (NASDAQ:NVLS) is one of the first spectacular failure stories of 2017. The company announced data from its lead cystic fibrosis trial end November, and the data did not read well...
Should You Buy Nivalis Therapeutics Inc (NVLS)?
Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock...
Biotech Movers And Shakers: Nivalis Therapeutics Inc (NVLS) And Amicus Therapeutics, Inc. (FOLD)
It’s time to take a look at those stocks that really moved over the last twenty-four hours or so in biotech, and there are plenty to go at. It’s been a big week for data so far (the conference schedule...
Ken Griffin And James Flynn Are Not Wasting Any Time Getting In On These New IPOs
Ken Griffin's (pictured) Citadel Investment Group has acquired about 1.09 million shares of 8Point3 Energy Partners LP (NASDAQ:CAFD). The holding represents about 5.4% of the $400 million utilities company...
Deerfield Management Bets Big On Company It Polished Ahead Of IPO, Nivalis Therapeutics Inc (NVLS)
Following the initial public offering of Nivalis Therapeutics Inc (NASDAQ:NVLS) today, James E. Flynn's Deerfield Management, which was a stakeholder of the company back in its private days, now holds...
Billionaire Hedge Funds
